Smad4 is essential for epiblast scaling and morphogenesis after implantation, but nonessential before implantation.

Abstract

Peer reviewed: TrueAcknowledgements: We thank the lab of Dr David Arnosti for their generous loan of laboratory equipment. We also thank Barbara Makela and Ella Markley for technical support. We thank Dr Melinda Frame and the Center for Advanced Microscopy at Michigan State University for their assistance with confocal microscopy, and thank MSU Campus Animal Resources for maintenance of our laboratory animals.Publication status: PublishedFunder: Michigan State UniversityBone morphogenic protein (BMP) signaling plays an essential and highly conserved role in embryo axial patterning in animal species. However, in mammalian embryos, which develop inside the mother, early development includes a preimplantation stage, which does not occur in externally developing embryos. During preimplantation, the epiblast is segregated from extra-embryonic lineages that enable implantation and development in utero. Yet, the requirement for BMP signaling is imprecisely defined in mouse early embryos. Here, we show that, in contrast to previous reports, BMP signaling (SMAD1/5/9 phosphorylation) is not detectable until implantation when it is detected in the primitive endoderm - an extra-embryonic lineage. Moreover, preimplantation development appears to be normal following deletion of maternal and zygotic Smad4, an essential effector of canonical BMP signaling. In fact, mice lacking maternal Smad4 are viable. Finally, we uncover a new requirement for zygotic Smad4 in epiblast scaling and cavitation immediately after implantation, via a mechanism involving FGFR/ERK attenuation. Altogether, our results demonstrate no role for BMP4/SMAD4 in the first lineage decisions during mouse development. Rather, multi-pathway signaling among embryonic and extra-embryonic cell types drives epiblast morphogenesis postimplantation

    Similar works

    Full text

    thumbnail-image